Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
View Patent ↗A cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof. The matrix suitable for preparation of cellular or acellular implants for growth and de novo formation of an articular hyaline-like cartilage. A gel-matrix composite system comprising collagen-based matrix having a narrowly defined porosity capable of inducing hyaline-like cartilage production from chondrocytes in vivo and in vitro.
1. An implant comprising:
a collagen scaffold comprising pores, having a basal surface and an apical surface each with openings to the pores, wherein at least 85% of the pores in the scaffold are vertically oriented; and
a suspension of chondrocytes seeded into the scaffold.
2. The implant of claim 1 , wherein at least 85% of the openings of the apical surface have a diameter of 200±100 micrometers.
3. The implant of claim 2 , wherein the apical surface has a pore density of 25±10 pores per mm 2 .
4. The implant of claim 1 , wherein at least 85% of the openings of the basal surface have a diameter of 200±100 micrometers.
5. The implant of claim 4 , wherein the basal surface has a pore density of 25±10 pores per mm 2 .
6. The implant of claim 1 , wherein at least 95% of the basal and apical openings have diameters of 200±100 micrometers.
7. The implant of claim 6 , wherein at least 98% of said basal and apical openings have diameters of 200±100 micrometers.
8. The implant of claim 1 , wherein the collagen scaffold comprises Type I collagen, Type II collagen, Type IV collagen or a combination thereof.
9. The implant of claim 1 , wherein the scaffold is formed by polymerizing a collagen solution in the presence of ammonia vapor.
10. The implant of claim 9 , wherein the collagen solution is polymerized at a reduced pressure.
11. The implant of claim 10 , wherein the collagen solution is polymerized at between 3 Torr and 10 Torr of pressure.
12. The implant of claim 9 , wherein the collagen solution comprises between 4 mg/ml and 8 mg/ml of Type I collagen in aqueous solution.
13. The implant of claim 12 , wherein the aqueous solution is acidic.
14. The implant of claim 12 , wherein the collagen solution comprises a non-ionic surfactant.
15. The implant of claim 14 , wherein the non-ionic surfactant comprises a polyoxyethylene-polyoxypropylene block copolymer.
16. The implant of claim 9 , further comprising freeze-drying the scaffold prior to seeding the scaffold with chondrocytes.
17. The implant of claim 1 , wherein the chondrocytes are seeded as a suspension of chondrocytes in a collagen solution.
18. The implant of claim 17 , wherein the collagen chondrocyte suspension has a concentration of 1 million to 12 million chondrocyte cells per mL of collagen solution.
19. The implant of claim 1 , wherein the chondrocytes comprise human articular chondrocytes.